KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Change in Receivables (2016 - 2025)

Astrana Health's Change in Receivables history spans 16 years, with the latest figure at $10.4 million for Q1 2025.

  • For Q1 2025, Change in Receivables rose 638.99% year-over-year to $10.4 million; the TTM value through Mar 2025 reached $53.4 million, up 90.25%, while the annual FY2024 figure was $44.4 million, 66.03% up from the prior year.
  • Change in Receivables for Q1 2025 was $10.4 million at Astrana Health, down from $41.4 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $47.5 million in Q3 2023 and bottomed at -$66.5 million in Q4 2022.
  • The 5-year median for Change in Receivables is $1.4 million (2024), against an average of $4.4 million.
  • The largest YoY upside for Change in Receivables was 19932.74% in 2022 against a maximum downside of 162346.34% in 2022.
  • A 5-year view of Change in Receivables shows it stood at $41000.0 in 2021, then plummeted by 162346.34% to -$66.5 million in 2022, then skyrocketed by 70.65% to -$19.5 million in 2023, then surged by 312.04% to $41.4 million in 2024, then tumbled by 74.96% to $10.4 million in 2025.
  • Per Business Quant, the three most recent readings for ASTH's Change in Receivables are $10.4 million (Q1 2025), $41.4 million (Q4 2024), and -$35.0 million (Q3 2024).